Is NCT03008447 results overdue?

Yes — results are overdue. Primary completion was 2018-01-03; the FDAAA-801 reporting deadline (2019-01-03) passed 2726 days ago and no results are posted on ClinicalTrials.gov.

Crossover Study to Evaluate the Effect of Lemborexant Versus Placebo and Zolpidem on Postural Stability, Auditory Awakening Threshold, and Cognitive Performance in Healthy Subjects 55 Years and Older

NCT ID	NCT03008447 ↗
Sponsor	Eisai Inc. (INDUSTRY)
Phase	PHASE1
Status	COMPLETED
Primary completion	2018-01-03 (ACTUAL)
Reporting deadline	2019-01-03 (completion + 365d)
Days overdue	2726
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-06-21 · SHA-256 `21796426d3a93f8d…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03008447. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.